C
BBIO icon

Covestor’s BridgeBio Pharma BBIO Stock Holding History

Covestor’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$156K Buy
2,093
+717
+52% +$50.2K 0.09% 182
2026
Q1 		$103K Sell
1,376
-198
-13% -$14.4K 0.07% 276
2025
Q4 		$121K Sell
1,574
-55
-3% -$3.61K 0.06% 466
2025
Q3 		$85K Sell
1,629
-3,206
-66% -$156K 0.05% 662
2025
Q2 		$209K Sell
4,835
-6,977
-59% -$254K 0.12% 162
2025
Q1 		$408K Sell
11,812
-9,156
-44% -$309K 0.27% 31
2024
Q4 		$576K Sell
20,968
-1,839
-8% -$47.5K 0.36% 26
2024
Q3 		$580K Buy
22,807
+10,432
+84% +$274K 0.36% 24
2024
Q2 		$313K Buy
12,375
+3,718
+43% +$102K 0.2% 56
2024
Q1 		$268K Buy
8,657
+1,406
+19% +$47.8K 0.17% 70
2023
Q4 		$292K Sell
7,251
-2,336
-24% -$70.2K 0.2% 45
2023
Q3 		$252K Buy
9,587
+5,446
+132% +$155K 0.19% 60
2023
Q2 		$71K Buy
4,141
+4,123
+22,906% +$62K 0.05% 628
2023
Q1 		$0 Hold
18
– – ﹤0.01% 2016
2022
Q4 		$0 Sell
18
-1
-5% -$10 ﹤0.01% 2063
2022
Q3 		$0 Sell
19
-3
-14% -$31 ﹤0.01% 1986
2022
Q2 		$0 Sell
22
-7
-24% -$59 ﹤0.01% 1906
2022
Q1 		$0 Sell
29
-88
-75% -$903 ﹤0.01% 2101
2021
Q4 		$2K Buy
+117
New +$4.95K ﹤0.01% 1518

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Covestor's BBIO Position: Q2 2026 in Review

Covestor increased its BridgeBio Pharma (BBIO) stake by 52% in Q2 2026, buying an estimated $50.2K and bringing the position to 2,093 shares worth $156K. The position accounts for 0.09% of the portfolio, ranked #182.

Covestor first reported a position in BBIO in Q4 2021 and has held it in 19 quarters since. The position peaked at $580K in Q3 2024. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Covestor held 2,093 shares of BridgeBio Pharma worth $156K as of Q2 2026.
  • Covestor bought 717 BridgeBio Pharma shares in Q2 2026, an estimated $50.2K.
  • BridgeBio Pharma made up 0.09% of Covestor's portfolio in Q2 2026, its #182 holding.
  • Covestor first reported a position in BridgeBio Pharma in Q4 2021 and has held it in 19 quarters since.
  • Covestor's BridgeBio Pharma position peaked at $580K in Q3 2024.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.